Share on StockTwits

Thermo Fisher Scientific (NYSE:TMO) EVP Alan J. Malus sold 13,115 shares of the stock on the open market in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $120.61, for a total value of $1,581,800.15. Following the transaction, the executive vice president now directly owns 99,840 shares in the company, valued at approximately $12,041,702. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

TMO has been the subject of a number of recent research reports. Analysts at Stifel Nicolaus initiated coverage on shares of Thermo Fisher Scientific in a research note on Monday, August 11th. They set a “buy” rating and a $150.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Thermo Fisher Scientific in a research note on Thursday, August 7th. They now have a $126.00 price target on the stock. Finally, analysts at Macquarie reiterated an “outperform” rating on shares of Thermo Fisher Scientific in a research note on Thursday, July 24th. They now have a $135.00 price target on the stock, up previously from $130.00. Two investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Thermo Fisher Scientific currently has an average rating of “Buy” and a consensus price target of $134.69.

Thermo Fisher Scientific (NYSE:TMO) traded down 0.01% on Thursday, hitting $120.07. The stock had a trading volume of 1,250,386 shares. Thermo Fisher Scientific has a 52 week low of $88.44 and a 52 week high of $127.63. The stock’s 50-day moving average is $121.1 and its 200-day moving average is $119.9. The company has a market cap of $47.950 billion and a P/E ratio of 31.21.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, July 23rd. The company reported $1.72 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.62 by $0.10. The company had revenue of $4.32 billion for the quarter, compared to the consensus estimate of $4.25 billion. During the same quarter last year, the company posted $1.32 earnings per share. Thermo Fisher Scientific’s revenue was up 33.4% compared to the same quarter last year. Analysts expect that Thermo Fisher Scientific will post $6.94 EPS for the current fiscal year.

Thermo Fisher Scientific Inc (NYSE:TMO) is engaged in serving science.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.